Helsinn Healthcare

Highly Engaged Employees

Helsinn Healthcare, established in 1976, operates within the Pharmaceuticals and Healthcare industries, specializing in active pharmaceutical ingredients (APIs) and finished dosage forms. The company's core strategy involves the in-licensing and out-licensing of pharmaceuticals and medical devices, focusing on niche therapeutic areas. Helsinn Healthcare develops medical compounds targeting oncology, cancer supportive care, pain, inflammation, and gastrointestinal conditions. The company markets its products globally through a network of selected local pharmaceutical partners, ensuring broad patient access to its specialized treatments. Helsinn Healthcare was formerly known as Helsinn S.A.

With facilities strategically located in Switzerland, Ireland, and the United States, alongside a representative office in Beijing, China, Helsinn Healthcare maintains a significant international presence. Employing between 500 - 1,000 professionals, the company leverages its expertise in R&D and state-of-the-art production to deliver high-quality pharmaceutical solutions. To learn more about the individuals driving its innovation, you can Meet Helsinn Healthcare's team. This operational structure supports its mission to address critical unmet medical needs in challenging therapeutic fields.

As a subsidiary of Helsinn Holding S.A., Helsinn Healthcare's business model is built on integrated global operations and strategic partnerships. This approach enables the effective commercialization of its pharmaceutical offerings and medical devices. The company's commitment to developing advanced therapies for oncology, pain management, and gastrointestinal health underscores its role as a key contributor to patient well-being worldwide. Its focus on quality and innovation positions it as a significant entity in the global pharmaceutical landscape.